Gregory Reyes
Net worth: - $ as of 2026-05-30
Net worth: - $ as of 2026-05-30
Gregory R.
Reyes is the founder of Orox Biosciences, Inc., founded in 2017.
Dr. Reyes currently serves as an Independent Director at Artelo Biosciences, Inc. since 2020.
Former positions include Senior VP-Drug Discovery & Head-San Diego Site at Celgene Corp.
from 2011 to 2016, Senior Vice President & Head-San Diego Site at Biogen, Inc. from 2008 to 2011, Vice President-Hepatitis Research at Genelabs Technologies, Inc., Vice President-Research & Development at Ingenex, Inc., Vice President-Molecular & Biological Research at Triplex Pharmaceutical Corp, Senior Vice President-Research at Bio Green Med Solution, Inc. from 2007 to 2008, VP-Biological Research & Infectious Diseases at Schering-Plough Research Institute, and Vice President-Discovery Biology at Pfizer (St. Louis).
Education includes a doctorate from The Johns Hopkins University and an undergraduate degree from the University of California, Santa Cruz.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-21 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Director/Board Member | 2020-11-29 |
| Companies | Position | End |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 2016-05-31 |
| BIOGEN INC. | Corporate Officer/Principal | 2011-05-31 |
| BIO GREEN MED SOLUTION, INC. | Chief Tech/Sci/R&D Officer | 2008-09-14 |
Orox Biosciences, Inc.
Orox Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that engages in discovery and development of small molecule medications | Founder | - |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Health Technology |
Ingenex, Inc.
Ingenex, Inc. BiotechnologyHealth Technology Part of Black Titan Corp., Ingenex, Inc. is a company based in San Francisco, CA. | Health Technology |
Artelo Biosciences, Inc.
Artelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops endocannabinoid system modulating therapeutics | Health Technology |
Triplex Pharmaceutical Corp
Triplex Pharmaceutical Corp Miscellaneous Commercial ServicesCommercial Services Biotechnology concern | Commercial Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Cruz
University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes mechanism-targeted drugs to treat human cancers | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Health Technology |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Orox Biosciences, Inc.
Orox Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that engages in discovery and development of small molecule medications | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions